Module 1: Lifestyle Management

Nutrition
Alice H. Lichtenstein, D.Sc; Linda Shiue, MD

  • Introduction to Nutrition & Cardiometabolic Health
  • The Role of Nutrition in Cardiometabolic Health
  • Assessment of nutritional status
  • Nutritional therapy and components
  • Guideline recommendations
  • Culinary medicine & Practical Nutritional Approaches


Physical Activity
John M. Jakicic, PhD

  • Introduction to Physical Activity & Cardiometabolic Health
  • The Role of Physical Activity in Cardiometabolic Health
  • Physical Activity Recommendations
  • Types of physical activity and evidence for cardiometabolic health
  • What type of PA is most beneficial based on underlying comorbidity (or comorbidities)


Smoking Cessation
Hilary A. Tindle, MD

  • Introduction/overview–role of smoking in increasing cardiometabolic risk
  • Assessment and screening of smoking status
  • Behavioral interviewing
  • Evidence-based strategies for smoking cessation (smoking cessation pharmacology, alternative tobacco products & more)


Sleep Medicine
Lee A. Surkin, MD; Christopher J. Lettieri, MD

  • Introduction/overview: The impact of sleep disorders on cardiometabolic risk/disease
  • Classification of sleep disorders
  • Assessment, diagnosis, clinical manifestations and management of sleep disorders

 

Questions? Email Foundations@cardiometabolichealth.org 

Target Audience

The Foundations of Cardiometabolic Health Certification Course is appropriate for clinicians from a full spectrum of clinical experience including Physicians, Physician Assistants, Nurse Practitioners, Registered Nurses, Pharmacists, Diabetologists, and Dietitians who are in any phase of training, or even experienced physicians who are looking to take a deeper dive into cardiometabolic health.

Learning Objectives

After completing this activity, the participant should be better able to:

  • Review the impact of diet and diet quality on cardiometabolic health.
  • Describe common elements of healthful eating patterns to promote cardiometabolic health according to evidence-based recommendations and guidelines.
  • Discuss physical activity guidelines for patients with chronic health conditions or with cardiometabolic risk factors.
  • Discuss the connections between sleep disorders or poor sleep and cardiometabolic health
  • Review the clinical presentation of various sleep disorders and their associated treatment options.
  • Develop individualized and comprehensive lifestyle approaches to reduce cardiometabolic risk, including incorporating healthful eating patterns, physical activity, smoking cessation advice, and assessment and adequate referral for sleep disorders.

Additional Information

Course summary
Available credit: 
  • 9.25 ABIM MOC and AMA PRA Category 1 Credit
  • 9.25 ACPE Pharmacy
  • 9.25 AMA PRA Category 1 Credit
  • 9.25 ANCC
  • 9.25 CDE
  • 9.25 Participation
Course opens: 
02/08/2022
Course expires: 
06/24/2025
Rating: 
0

Alice H. Lichtenstein, D.Sc., FAHA
Gershoff Professor of Nutrition Science and Policy, Friedman School
Director and Senior Scientist, Cardiovascular
Nutrition Laboratory, JM USDA Human
Nutrition Research Center on Aging
Tufts University, Boston, MA

Dr. Lichtenstein has no relevant financial relationships to disclose.

 

Linda Shiue, MD, Chef

Dr. Shiue has no relevant financial relationships to disclose.

 

John M. Jakicic, PhD
Professor
Director, Translational Health and Applied Energy
Balance Laboratories
University of Kansas Medical Center
Department of Internal Medicine
Division of Physical Activity and Weight Management
Kansas City, KS

Dr. Jakicic discloses the following:
Consultant: WW International, Inc., Wondr Health

 

Hilary A. Tindle, MD, MPH
Associate Professor of Medicine
William Anderson Spickard, Jr., MD, Chair in Medicine
Director of ViTAL: Vanderbilt Center for Tobacco, Addiction and Lifestyle
Vanderbilt University Medical Center
Nashville, TN

Dr. Tindle discloses the following: 

  • Principal Investigator for NIH-supported smoking cessation trials that used smoking cessation medication donated by manufacturer
  • Consultant to NCI for Tobacco Control Monograph Series, to CDC for U.S. Surgeon General’s Reports on Smoking and Tobacco Use
  • Volunteered (unpaid) scientific input to design of a Phase 3 trial for an emerging smoking cessation medication proposed for FDA approval
  • Currently volunteer as panel member for:
    • National Comprehensive Cancer Center (NCCN) Smoking Cessation Guidelines
    • Cochrane Review Guidelines for Treating Hospitalized Smokers (2022 Update)

 

Lee A. Surkin, MD, FACC, FCCP, FASNC, FAASM
Founder, American Academy of Cardiovascular Sleep Medicine
President, Empire Sleep Medicine

Dr. Surkin discloses the following:
Consultant: Jazz Pharmaceuticals

 

Christopher J. Lettieri, MD, FACP, FCCP, FAASM
Professor of Medicine, Uniformed Services University of the Health Sciences
Rockville, MD

Dr. Lettieri has no relevant financial relationships to disclose.

ESTIMATED TIME TO COMPLETE ACTIVITY
9.25 hours

JOINT ACCREDITATION STATEMENT
    image

In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and Tarsus Cardio Inc. dba Cardiometabolic Health Congress (CMHC). PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIAN CONTINUING MEDICAL EDUCATION
Partners for Advancing Clinical Education designates this enduring material for a maximum of 9.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CONTINUING NURSING EDUCATION
The maximum number of hours awarded for this Continuing Nursing Education activity is 9.25 contact hours. Pharmacotherapy contact hours for Advanced Practice Registered Nurses will be designated on your certificate.

CONTINUING PHARMACY EDUCATION
Partners for Advancing Clinical Education designates this continuing education activity for 9.25 contact hour(s) (0.925 CEUs) of the Accreditation Council for Pharmacy Education.

This is an application-based activity. Universal Activity Numbers (UAN): JA4008073-9999-22-001-H01-P

For Pharmacists: Upon completing the post-test and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 – 6 weeks.

CONTINUING DIETICIAN EDUCATION
This program offers 9.25 CPEUs for dieticians.

ABIM MOC CERTIFICATION

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 9.25 MOC points in the American Board of Internal Medicine's (ABIM) maintenance of certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

MERIT-BASED INCENTIVE PAYMENT PROGRAM (MIPS)

Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS).

DISCLOSURE OF CONFLICTS OF INTEREST
Partners for Advancing Clinical Education (PACE) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to PACE policy. PACE is committed to providing learners with high-quality accredited CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The PACE planners and others have nothing to disclose. The CMHC planners and others have nothing to disclose.

DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA.  The planners of this activity do not recommend the use of any agent outside of the labeled indications.  The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners.  Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management.  Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

METHOD OF PARTICIPATION & REQUEST FOR CREDIT
During the period Febuary 7, 2022 through June 24, 2023, participants must read the learning objectives and faculty disclosures, study the educational activity, obtain a score of 75% or better on the post-test, and complete the evaluation. Upon completing, your certificate will be available for print. For questions about receiving certificates, please contact us at Foundations@cardiometabolichealth.org.

For questions about the accreditation of this activity, please visit www.clinicaleducationalliance.com.

For Pharmacists: Please complete the evaluation instructions above. Upon registering and completing the activity evaluation, your transcript information will be sent to the NABP CPE Monitor Service within 4-6 weeks.

For MIPS:
1) Complete this module post-test and evaluation.
2) Over the next 90 days, actively work to incorporate improvements in your clinical practice from these presentations.
3) Complete the follow-up survey from CMHC in approximately 90 days.

Available Credit

  • 9.25 ABIM MOC and AMA PRA Category 1 Credit
  • 9.25 ACPE Pharmacy
  • 9.25 AMA PRA Category 1 Credit
  • 9.25 ANCC
  • 9.25 CDE
  • 9.25 Participation
 
Status
Price
Title
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.
Please login or register to take this course.

Required Hardware/software

A computer with an internet connection

Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser

Other additional software may be required such as PowerPoint or Adobe Acrobat Reader.